Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripheral T Cell Lymphoma
Apply
Durvalumab & Lenalidomide
Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripheral T Cell Lymphoma
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step